The fight against malaria : Is it SP, SP+Artesunate or Coartem®
Siana Nkya
Broschiertes Buch

The fight against malaria : Is it SP, SP+Artesunate or Coartem®

The study OF SP, SP+Artesunate and Coartem® efficacy and the frequency of mutant genotypes in south-east Asia

Versandkostenfrei!
Versandfertig in 6-10 Tagen
25,99 €
inkl. MwSt.
PAYBACK Punkte
13 °P sammeln!
In establishing the efficacy of an antimalarial drug, discriminating recurrent infections caused by the same parasites (recrudescent) present before the onset of treatment from new infections is important. This is to avoid overestimation of treatment failures, which may lead to inaccurate efficacy evaluation. Three years after its launch in Tanzania (2001), Sulphadoxine-Pyrimethamine (SP) started to show low efficacy due to high frequencies of recurrent malaria episodes caused by recrudescent parasites. It was time for Tanzania to consider newer combination therapies such as SP+ Artesunate and...